Post Date:Feb-08-22
Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy
Author: AcceGen R&D TeamDate Published: 08-Feb-22
Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy
- Authors: Yingnan Si, Seulhee Kim, Jianfa Ou, Yun Lu, Patrick Ernst, Kai Chen, Jason Whitt, Angela M. Carter, James M. Markert, James A. Bibb, Herbert Chen, Lufang Zhou, Renata Jaskula-Sztul & Xiaoguang “Margaret” Liu
- Journal: Cancer Gene Therapy
- DOI: 10.1038/s41417-020-0196-5
- Cited AcceGen Product/Service: QGP-1
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com
